Skip to content

Roche Holding AG Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: April 23, 2026 results vs estimates

Roche Holding AG · E.RO.SW · Switzerland
Use symbol E.RO.SW in our API & Excel add-in to retrieve this data ↓
409.40
(+0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 19.87%

Roche Holding AG Forecast

Roche Holding AG short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 19.9% a year, a typical one-standard-deviation range is 397.94–420.86 over a week, 385.92–432.88 over a month and 328.05–490.75 over a year. (Signals as of 1 Nov 2026.)

Roche Holding AG Price Chart

MacroFinance.ai

Roche Holding AG Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Roche Holding AG
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Roche Holding AG
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Roche Holding AG
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Roche Holding AG
P/E
15.22x
Stretched vs own history
QoQ +7.9%
YoY +16.5%
now 15.218611.75 low15.32 high
ⓘP/E As of 22 Nov 2026.See Roche Holding AG returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Roche Holding AG
P/S
2.68x
Stretched vs own history
QoQ +7.9%
YoY +25.2%
now 2.68232.01 low2.7 high
ⓘP/S As of 22 Nov 2026.See Roche Holding AG returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Roche Holding AG
P/B
10.13x
Mid-range vs own history
QoQ +7.9%
YoY +11.0%
now 10.1347.35 low10.2 high
ⓘP/B As of 22 Nov 2026.See Roche Holding AG returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Roche Holding AG
EV/EBITDA
8.88x
Stretched vs own history
QoQ +7.3%
YoY +11.0%
now 8.88366.8 low8.94 high
ⓘEV/EBITDA As of 22 Nov 2026.See Roche Holding AG returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Roche Holding AG
EV/Sales
2.86x
Stretched vs own history
QoQ +7.3%
YoY +22.9%
now 2.86092.15 low2.88 high
ⓘEV/Sales As of 22 Nov 2026.See Roche Holding AG returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Roche Holding AG
FCF Yield
9.2%
Mid-range vs own history
QoQ −7.3%
YoY −9.8%
now 9.17549.12 low12.3 high
ⓘFCF Yield As of 22 Nov 2026.See Roche Holding AG returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Roche Holding AG
Earnings Yield
6.6%
Weak vs own history
QoQ −7.3%
YoY −14.1%
now 6.57096.53 low8.51 high
ⓘEarnings Yield As of 22 Nov 2026.See Roche Holding AG returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Roche Holding AG
Dividend Yield
6.1%
Mid-range vs own history
QoQ −7.3%
YoY −17.8%
now 6.14676.11 low8.13 high
ⓘDividend Yield As of 22 Nov 2026.See Roche Holding AG returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Roche Holding AG
Market Cap
$331.3B
Highest in 5 years
QoQ +7.9%
YoY +26.5%
now 331309.8158248,609 low333,414 high
ⓘMarket Cap As of 22 Nov 2026.See Roche Holding AG returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Roche Holding AG
Net Debt
$22.1B
Mid-range vs own history
QoQ 0.0%
YoY −2.4%
now 2207117,715 low22,607 high
ⓘNet Debt As of 22 Nov 2026.See Roche Holding AG returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Roche Holding AG
Net Debt / EBITDA
0.55x
Mid-range vs own history
QoQ 0.0%
YoY −12.7%
now 0.55480.45 low0.64 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Roche Holding AG returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Roche Holding AG
Current Ratio
1.23x
Mid-range vs own history
QoQ 0.0%
YoY −5.1%
now 1.22841.23 low1.38 high
ⓘCurrent Ratio As of 22 Nov 2026.See Roche Holding AG returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Roche Holding AG
Quick Ratio
0.95x
Mid-range vs own history
QoQ 0.0%
YoY −7.0%
now 0.94790.95 low1.12 high
ⓘQuick Ratio As of 22 Nov 2026.See Roche Holding AG returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Roche Holding AG
Interest Coverage
12.59x
12.59x
QoQ 0.0%
YoY −0.1%
now 12.591812.46 low12.6 high
ⓘInterest Coverage As of 22 Nov 2026.See Roche Holding AG returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Roche Holding AG
Debt / Equity
0.97x
Mid-range vs own history
QoQ 0.0%
YoY −19.4%
now 0.97280.97 low1.21 high
ⓘDebt / Equity As of 22 Nov 2026.See Roche Holding AG returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Roche Holding AG
Piotroski F-Score
5
Mid-range vs own history
QoQ 0.0%
YoY −37.5%
now 55 low9 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Roche Holding AG returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Roche Holding AG
Altman Z-Score
6.36
Strong vs own history
QoQ +3.8%
YoY +14.0%
now 6.35545.47 low6.38 high
ⓘAltman Z-Score As of 22 Nov 2026.See Roche Holding AG returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  16 members-only factors: Revenue Growth, Earnings Growth, EBITDA Growth, FCF Growth and moreSign up
Accounting Red Flags
  17 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Roche Holding AG, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Roche Holding AG fundamentals: income statement, balance sheet & cash flow

Roche Holding AG reported revenue of 61.52bn CHF and net income of 12.88bn CHF in FY2025, the year ended 31 December 2025 — revenue down 1.4% and net income up 55.6% on the prior year. Free cash flow was 14.08bn CHF. These figures are as reported in the filings, not restated: 28 fiscal years and 109 quarters of history, back to December 1998.

Revenue (FY2025)
61.52bn CHF
-1.4%
Net income
12.88bn CHF
+55.6%
Gross margin
73.53%
Free cash flow
14.08bn CHF
-6.6%
Net debt
27.61bn CHF
Roche Holding AG income statement, annual, as reported · CHF billions unless stated
CHF billionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue61.5262.4060.4465.8162.80
Cost of revenue16.2816.2816.3617.9419.70
Gross profit45.2446.1144.0847.8843.10
Research & development13.3515.3014.2015.2314.80
Operating income19.2613.4215.4017.4818.16
EBITDA22.6516.6218.4020.8022.19
Interest expense1.351.250.830.610.34
Pre-tax income16.9711.7914.0816.3717.40
Income tax3.172.611.722.802.46
Net income12.888.2811.5012.4213.93

Download Roche Holding AG fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.RO.SW&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 28 fiscal years and 109 quarters, the filing vintages behind each number and API access.
Create free account

Figures in CHF, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Roche Holding AG

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Roche Holding AG Trading Strategies

9 backtested tactical asset allocation strategies hold VGK (European market), the closest tradable exposure to Roche Holding AG; 1 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

Explore all strategies →

Statistical Distribution of Returns

Plus

How Roche Holding AG’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Roche Holding AG behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Roche Holding AG (Switzerland)

Roche Holding AG is a listed security in Switzerland. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Roche Holding AG

Frequently asked questions

What is Roche Holding AG?
Roche Holding AG is a listed security in Switzerland. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Roche Holding AG price?
The latest close is 409.4 (1 Nov 2026), +0.01% on the day. The price at the top of the page refreshes during the trading day.
Is Roche Holding AG in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Roche Holding AG?
20-day realised volatility is 19.9% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 5.7% over a month and 2.8% over a week.
What factors affect Roche Holding AG?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Roche Holding AG, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Roche Holding AG?
9 backtested tactical asset allocation strategies trade Roche Holding AG through VGK; 1 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Roche Holding AG returns analysed?
The Statistical Distribution of Returns section shows the distribution of Roche Holding AG daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Roche Holding AG historical data?
In the Free historical data section of this page: the last 10 years of Roche Holding AG daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Roche Holding AG historical data (last 10 years)

Browse or instantly download the last 10 years of Roche Holding AG daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.RO.SW&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20402.6
2026-11-19405
2026-11-18407.6
2026-11-17411
2026-11-16414.2
2026-11-13412
2026-11-12415.8
2026-11-11411.4
2026-11-10410.4
2026-11-09410
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.